Last update: March 17, 2019

Anti-parkinson drugs: Anticholinergics & Dopaminergic agents. ATC N04

Biperiden (belonging to Anti-parkinson drugs: Anticholinergics & Dopaminergic agents. ATC N04):

Decreased level of risk

New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was High Risk probable, is now set to Low Risk probable.

Level of risk reviewed on Feb. 7, 2019

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Groups related with Anti-parkinson drugs: Anticholinergics & Dopaminergic agents. ATC N04

Total visits

2,223

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM